(Q31805769)

4 July 2017

title

[18F]-EF5, a marker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure (English)

1 reference

4 July 2017

0 references

Dolbier WR Jr

1

1 reference

4 July 2017

Li AR

2

1 reference

4 July 2017

Koch CJ

3

1 reference

4 July 2017

Shiue CY

4

1 reference

4 July 2017

Kachur AV

5

1 reference

4 July 2017

publication date

1 January 2001

1 reference

Applied Radiation and Isotopes

4 July 2017

published in

1 reference

4 July 2017

volume

54

1 reference

4 July 2017

issue

1

1 reference

4 July 2017

page(s)

73-80

1 reference

Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2800%2900102-0

7 January 2021

Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide].

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2800%2900102-0

7 January 2021

Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2800%2900102-0

7 January 2021

Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: potential in vivo markers of hypoxic tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2800%2900102-0

7 January 2021

Synthesis of new hypoxia markers EF1 and [18F]-EF1

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2800%2900102-0

7 January 2021

Metabolism induced binding of 14C-misonidazole to hypoxic cells: kinetic dependence on oxygen concentration and misonidazole concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2800%2900102-0

7 January 2021

Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide] : analysis of drug adducts by fluorescent antibodies vs bound radioactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2800%2900102-0

7 January 2021

Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2800%2900102-0

7 January 2021

Positron emission tomography. A new tool for characterization of malignant disease and selection of therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2800%2900102-0

7 January 2021

Radiolabeled hypoxic cell sensitizers: tracers for assessment of ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2800%2900102-0

7 January 2021

Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2800%2900102-0

7 January 2021

Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2800%2900102-0

7 January 2021

Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2800%2900102-0

7 January 2021

Synthesis of [18F]fluoroetanidazole: a potential new tracer for imaging hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2800%2900102-0

7 January 2021

Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2800%2900102-0

7 January 2021

Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0969-8043%2800%2900102-0

7 January 2021

10.1016/S0969-8043(00)00102-0

Identifiers

DOI

1 reference

4 July 2017

1 reference